Coivas logo

Coivas Review

7.7
★★★★☆3.9/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10

Best for: all-inclusive compounded GLP-1 at one flat price per dose, with a conditional money-back guarantee

Coivas scores highest on trust and safety in our breakdown.

Semaglutide

$249/mo

Tirzepatide

$299/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Coivas is an all-inclusive compounded GLP-1 telehealth service operated by WellVi LLC, with care from independent clinicians through Beluga Health. Compounded semaglutide is $249/mo month-to-month ($178/mo on the quarterly plan) and tirzepatide is $299/mo ($254/mo quarterly), the same price at every dose, covering the clinician review, medication, shipping and support. It says it serves all 50 states and offers a conditional money-back guarantee.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideAll-Inclusive PriceSame Price Every DoseFree ShippingMoney-Back GuaranteeLegitScript Verified

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Coivas

7.7/ 10
Verified partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Verified partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Coivas logo
3.9 / 5
Our editorial rating
Visit Coivas →

from $249/mo · no insurance needed

Coivas at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$249/mo
Pricing model
Flat: dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Coivas

Each dimension is scored algorithmically from Coivas’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.8/10

At $249/mo, Coivas runs about 35% above the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

8.3/10

Coivas offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.6/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

9.0/10

Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.

Accessibility10%

8.5/10

Coivas treats patients in all 50 states.

Support10%

6.1/10

Coivas provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
669providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Coivas review

Last checked October 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

Provider's own pricing page
$249–$299/mo across 2 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Coivas

We walked Coivas’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Pick semaglutide or tirzepatide on the treatment page and toggle between the quarterly and monthly price.
  2. 2Tap See if you qualify or Get started to open Coivas' online intake.
  3. 3The first intake screen asks for your height, weight, goal weight, shipping state, date of birth and health history.
Price shown before you start
  • Treatment pages show the full price before intake: semaglutide $249/mo monthly or $178/mo quarterly; tirzepatide $299/mo monthly or $254/mo quarterly.
  • The homepage advertises 'from $119/mo' and 'from $199/mo' with a promo banner, which doesn't match the plan prices on the treatment pages.
  • Prices are listed as the same at every dose, with no membership or per-visit fees.
  • The Challenge page promises a 3-month money-back trial, while the Terms require 6 months of continuous enrollment.
  • Cancellation is self-serve in the patient portal; shipped medication can't be returned.

Coivas customer support

GLP-1 medications Coivas offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Month-to-month, any doseCompounded
$249/mo
semaglutide

$249 billed monthly; same price at every dose; includes clinician review, medication, shipping and support. Longer plan: quarterly $178/mo ($534 every 3 months).

Month-to-month, any doseCompounded
$299/mo
tirzepatide

$299 billed monthly; same price at every dose; includes clinician review, medication, shipping and support. Longer plan: quarterly $254/mo ($762 every 3 months).

Ready to get started?

Plans and promotions change often, so check Coivas's current pricing and active discounts before you decide.

See Coivas pricing →

What we like

  • One price covers the clinician review, medication, shipping and support, with no membership fee
  • Same price at every dose, so your cost doesn't climb as your dose goes up
  • Quarterly plan lowers the cost to $178/mo for semaglutide and $254/mo for tirzepatide
  • LegitScript seal on the site, and it names its clinical provider network (Beluga Health)
  • Available in all 50 states; HSA/FSA eligible; cancel anytime from the patient portal

Watch-outs

  • Month-to-month pricing is high: $249/mo for semaglutide and $299/mo for tirzepatide
  • The lowest rates need a quarterly plan billed $534 or $762 every 3 months
  • Homepage 'from $119/mo' and 'from $199/mo' figures don't match the plan prices on its own treatment pages
  • Money-back guarantee needs 6 months of continuous enrollment with strict conditions, though the Challenge page says 3 months
  • Dispensing pharmacies are described only by type (503A/503B), not named
  • Compounded injectables only, no brand-name options; binding arbitration in New York

Is Coivas worth it?

Coivas built its program around one core idea: all-inclusive compounded GLP-1 at one flat price per dose, with a conditional money-back guarantee. It runs $249/month at every dose, a premium versus the rest of the category, so its specific extras need to earn the difference. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.

Coivas charges the same price at every dose. It also refunds you if it doesn't work out and is LegitScript-certified.

How much Coivas costs

Compounded semaglutide runs $249/month and compounded tirzepatide runs $299/month.

For context, the median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide) is around $185/month. Coivas's standing rate sits at the premium end of that range, well above the cheapest options in the category.

For a direct comparison, Wellorithm runs semaglutide and tirzepatide from $247/month, so compare it with Coivas before you commit.

Medications: what Coivas prescribes

Coivas prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.

Who Coivas is best for, and who should skip it

A good fit if you…

  • live anywhere in the US and want the certainty that your state is already covered.

Look elsewhere if you…

  • want the lowest total cost over 6–12 months, where a flat-rate provider like altRX will likely beat the ongoing price.
  • specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

Coivas treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Coivas costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, PlexusDx is one of the closest alternatives we track; compare the two before deciding.

The Bottom Line

Coivas scores highest on trust and safety in our breakdown.

Score: 7.7/10Best for: all-inclusive compounded GLP-1 at one flat price per dose, with a conditional money-back guaranteeFrom: $249/mo

Ready to start with Coivas?

From $249/mo. See current pricing and start your free consultation.

Coivas might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Coivas vs…

Coivas scores7.7/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Coivas is a telehealth platform operated by WellVi LLC that connects you with independent licensed clinicians through Beluga Health. You complete a short online intake, a clinician decides whether compounded semaglutide or tirzepatide is appropriate, and medication ships from a licensed U.S. pharmacy.
Coivas offers compounded semaglutide and compounded tirzepatide injections. It lists oral GLP-1s as coming soon and does not offer brand-name GLP-1s. Compounded medications are not FDA-approved finished products.
Compounded semaglutide is $249/mo month-to-month or $178/mo on the quarterly plan ($534 every 3 months). Tirzepatide is $299/mo month-to-month or $254/mo quarterly ($762 every 3 months). The price is the same at every dose and covers the clinician review, medication, shipping and support.
Coivas says it is available in all 50 states. It is self-pay and does not bill insurance, though most plans are HSA/FSA eligible.
Under its Terms, you must stay continuously enrolled for at least six months on compounded semaglutide or tirzepatide, follow your clinician's instructions, and document that your final weight is at or above your starting weight. It is not prorated, and any pause, cancellation or missed refill voids it. The Challenge page advertises 3 months, so read the Terms before relying on it.
Yes. You can cancel anytime from your patient portal or by emailing support. Cancel before your next shipment is processed to avoid the following charge. Shipped medication can't be returned, but you can get a refund for a visit that never happened, a prescription that wasn't issued, or a duplicate charge.
Coivas doesn't use public promo or coupon codes: its $249/month includes the medication and the clinician visits, with no insurance or coupons needed. Third-party sites advertising "Coivas discount codes" are typically fake; any current offer applies automatically through the link on this page.
Yes. Coivas is a legitimate telehealth provider, and it's LegitScript-certified. Our editors independently verified its pricing and offering and scored it 7.7/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Month-to-month pricing is high: $249/mo for semaglutide and $299/mo for tirzepatide; The lowest rates need a quarterly plan billed $534 or $762 every 3 months; Homepage 'from $119/mo' and 'from $199/mo' figures don't match the plan prices on its own treatment pages; Money-back guarantee needs 6 months of continuous enrollment with strict conditions, though the Challenge page says 3 months. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Coivas review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Coivas's current pricing

Plans from $249/mo. Start your free consultation to check eligibility and today's price.